SCHEMBL7692245

SCHEMBL7692245

CN(C)Cc1ccc(C=Cc2ccccc2C(=O)NC(CC2CCCCC2)C(=O)CNS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 8/20 0.51
CTSB P07858 7/20 0.51
CTSS P25774 3/20 0.44
CTSK P43235 3/20 0.44
USP30 Q70CQ3 4/20 0.40
CTSL P07711 3/20 0.39
MMP13 P45452 1/20 0.37
OPRM1 P35372 2/20 0.36
OPRK1 P41145 2/20 0.36
CASP1 P29466 2/20 0.35
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688501 0.86 CAPN1 (0.58) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7692161 0.84 CAPN1 (0.70) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7694140 0.78 CAPN1 (0.60) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7689922 0.76 CAPN1 (0.57) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697278 0.76 CAPN1 (0.47) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697381 0.75 CAPN1 (0.50) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7691261 0.75 CAPN1 (0.47) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7695233 0.74 CAPN1 (0.54) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7690197 0.74 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697613 0.73 CAPN1 (0.52) CAPN1CTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed